ASD-005

N/A

Report date: 2025/01/26 17:28:21
NME

Base Information

Drug NameASD-005
Drug Alias NameASD-005
ClassificationSmall molecules > Carbohydrate > Oligosaccharide
Mechanisms of ActionMicrotubule-associated protein tau modulatorsBeta amyloid A4 protein modulators
TargetsMicrotubule-associated protein tauBeta amyloid A4 protein
Therapy Area/IndicationsLysosomal Storage DiseasesAmyotrophic Lateral SclerosisFrontotemporal Dementia +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAsdera
China Registration ClassN/A

Develop Information

Active CompaniesAsdera
Inactive CompaniesN/A
Active IndicationsLysosomal Storage DiseasesAmyotrophic Lateral SclerosisFrontotemporal Dementia +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A